Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
Crinetics Pharmaceuticals Net Income (TTM) : -501.61M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -501.61M |
| March 31, 2026 | -496.39M |
| December 31, 2025 | -465.32M |
| September 30, 2025 | -423.10M |
| June 30, 2025 | -369.83M |
| March 31, 2025 | -328.25M |
| December 31, 2024 | -298.41M |
| September 30, 2024 | -277.91M |
| June 30, 2024 | -258.54M |
| March 31, 2024 | -235.46M |
| December 31, 2023 | -214.53M |
| September 30, 2023 | -199.42M |
| June 30, 2023 | -183.89M |
| March 31, 2023 | -175.29M |
| December 31, 2022 | -163.92M |
| September 30, 2022 | -149.72M |
| June 30, 2022 | -135.65M |
| March 31, 2022 | -119.37M |
| Date | Value |
|---|---|
| December 31, 2021 | -107.64M |
| September 30, 2021 | -98.49M |
| June 30, 2021 | -88.96M |
| March 31, 2021 | -79.35M |
| December 31, 2020 | -73.81M |
| September 30, 2020 | -66.72M |
| June 30, 2020 | -62.83M |
| March 31, 2020 | -58.77M |
| December 31, 2019 | -50.42M |
| September 30, 2019 | -44.37M |
| June 30, 2019 | -37.53M |
| March 31, 2019 | -30.67M |
| December 31, 2018 | -27.12M |
| September 30, 2018 | -21.14M |
| June 30, 2018 | -15.94M |
| March 31, 2018 | -12.02M |
| December 31, 2017 | -9.157M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Bristol Myers Squibb Co. | 9.275B |
| Corcept Therapeutics, Inc. | 54.20M |